Robert Griggs

Experimental Neurotherapeutics Training Program

National Institute of Neurological Disorders and Stroke · T32

Contact PI · $7.5M · University of Rochester

FOR-DMD: Double-Blind Randomized Trial to Optimize Steroid Regimen in Duchenne MD

National Institute of Neurological Disorders and Stroke · U01

Contact PI · $13.7M · University of Rochester

Neurotherapeutics Symposium 2019 – Accelerating the Pace of Translation in Neurological Emergencies by Enhancing Diverse Workforce in Neuroscience and Promoting Transdisciplinary Team Science

National Institute of Neurological Disorders and Stroke · R13

PI · $20K · University of Florida

Economic Considerations in the Development of Therapies for Neuromuscular Disease

National Institute of Neurological Disorders and Stroke · R13

Contact PI · $25.5K · University of Rochester

Finding the Optimum Regimen for Duchenne Muscular Dystrophy

Principal investigator · Completed · Phase 3

University of Rochester

Characteristics of Andersen-Tawil Syndrome

Principal investigator · Completed

University of Rochester

Hyper- and Hypokalemic Periodic Paralysis Study

Principal investigator · Completed · Phase 3

University of Rochester

Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy

Study chair · Completed

National Center for Research Resources (NCRR)